Department of Obstetrics and Gynecology, Tongji Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, Hubei, China.
Department of Pulmonary and Critical Care Medicine, Tongji Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, Hubei, China.
J Am Geriatr Soc. 2020 Jun;68(6):E19-E23. doi: 10.1111/jgs.16533. Epub 2020 May 12.
BACKGROUND/OBJECTIVES: Previous studies have reported that older patients may experience worse outcome(s) after infection with severe acute respiratory syndrome coronavirus-2 than younger individuals. This study aimed to identify potential risk factors for mortality in older patients with coronavirus disease 2019 (COVID-19) on admission, which may help identify those with poor prognosis at an early stage.
Retrospective case-control.
Fever ward of Sino-French New City Branch of Tongji Hospital, Wuhan, China.
Patients aged 60 years or older with COVID-19 (n = 244) were included, of whom 123 were discharged and 121 died in hospital.
Data retrieved from electronic medical records regarding symptoms, signs, and laboratory findings on admission, and final outcomes of all older patients with COVID-19, were retrospectively reviewed. Univariate and multivariate logistic regression analyses were used to explore risk factors for death.
Univariate analysis revealed that several clinical characteristics and laboratory variables were significantly different (ie, P < .05) between discharged and deceased patients. Multivariable logistic regression analysis revealed that lymphocyte (LYM) count (odds ratio [OR] = 0.009; 95% confidence interval [CI] = 0.001-0.138; P = .001) and older age (OR = 1.122; 95% CI = 1.007-1.249; P = .037) were independently associated with hospital mortality. White blood cell count was also an important risk factor (P = .052). The area under the receiver operating characteristic curve in the logistic regression model was 0.913. Risk factors for in-hospital death were similar between older men and women.
Older age and lower LYM count on admission were associated with death in hospitalized COVID-19 patients. Stringent monitoring and early intervention are needed to reduce mortality in these patients. J Am Geriatr Soc 68:E19-E23, 2020.
背景/目的:先前的研究报告称,感染严重急性呼吸综合征冠状病毒 2 后,老年患者的预后可能比年轻患者差。本研究旨在确定入院时患有 2019 年冠状病毒病(COVID-19)的老年患者死亡的潜在危险因素,这有助于在早期识别预后不良的患者。
回顾性病例对照。
中国武汉同济医院中法新城院区发热病房。
纳入年龄在 60 岁及以上的 COVID-19 患者(n = 244),其中 123 例出院,121 例在院死亡。
回顾性分析所有老年 COVID-19 患者入院时的症状、体征和实验室检查结果及最终结局的电子病历数据。采用单因素和多因素 logistic 回归分析探讨死亡的危险因素。
单因素分析显示,出院组与死亡组之间有几个临床特征和实验室变量差异有统计学意义(即 P <.05)。多因素 logistic 回归分析显示,淋巴细胞(LYM)计数(比值比[OR] = 0.009;95%置信区间[CI] = 0.001-0.138;P =.001)和高龄(OR = 1.122;95% CI = 1.007-1.249;P =.037)与住院死亡率独立相关。白细胞计数也是一个重要的危险因素(P =.052)。logistic 回归模型的受试者工作特征曲线下面积为 0.913。老年男性和女性住院死亡的危险因素相似。
入院时年龄较大和 LYM 计数较低与住院 COVID-19 患者死亡相关。需要严格监测和早期干预,以降低这些患者的死亡率。美国老年学会杂志 68:E19-E23,2020。